PMID- 38255008 OWN - NLM STAT- MEDLINE DCOM- 20240124 LR - 20240201 IS - 2073-4425 (Electronic) IS - 2073-4425 (Linking) VI - 15 IP - 1 DP - 2024 Jan 18 TI - Sodium Channel Gene Variants in Fetuses with Abnormal Sonographic Findings: Expanding the Prenatal Phenotypic Spectrum of Sodium Channelopathies. LID - 10.3390/genes15010119 [doi] LID - 119 AB - Voltage-gated sodium channels (VGSCs) are responsible for the initiation and propagation of action potentials in the brain and muscle. Pathogenic variants in genes encoding VGSCs have been associated with severe disorders including epileptic encephalopathies and congenital myopathies. In this study, we identified pathogenic variants in genes encoding the alpha subunit of VGSCs in the fetuses of two unrelated families with the use of trio-based whole exome sequencing, as part of a larger cohort study. Sanger sequencing was performed for variant confirmation as well as parental phasing. The fetus of the first family carried a known de novo heterozygous missense variant in the SCN2A gene (NM_001040143.2:c.751G>A p.(Val251Ile)) and presented intrauterine growth retardation, hand clenching and ventriculomegaly. Neonatally, the proband also exhibited refractory epilepsy, spasms and MRI abnormalities. The fetus of the second family was a compound heterozygote for two parentally inherited novel missense variants in the SCN4A gene (NM_000334.4:c.4340T>C, p.(Phe1447Ser), NM_000334.4:c.3798G>C, p.(Glu1266Asp)) and presented a severe prenatal phenotype including talipes, fetal hypokinesia, hypoplastic lungs, polyhydramnios, ear abnormalities and others. Both probands died soon after birth. In a subsequent pregnancy of the latter family, the fetus was also a compound heterozygote for the same parentally inherited variants. This pregnancy was terminated due to multiple ultrasound abnormalities similar to the first pregnancy. Our results suggest a potentially crucial role of the VGSC gene family in fetal development and early lethality. FAU - Hadjipanteli, Andrea AU - Hadjipanteli A AUID- ORCID: 0009-0008-4401-7513 AD - The Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, 2371 Nicosia, Cyprus. FAU - Theodosiou, Athina AU - Theodosiou A AUID- ORCID: 0000-0003-4363-8162 AD - The Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, 2371 Nicosia, Cyprus. FAU - Papaevripidou, Ioannis AU - Papaevripidou I AD - The Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, 2371 Nicosia, Cyprus. FAU - Evangelidou, Paola AU - Evangelidou P AUID- ORCID: 0000-0001-5565-0666 AD - The Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, 2371 Nicosia, Cyprus. FAU - Alexandrou, Angelos AU - Alexandrou A AD - The Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, 2371 Nicosia, Cyprus. FAU - Salameh, Nicole AU - Salameh N AD - The Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, 2371 Nicosia, Cyprus. FAU - Kallikas, Ioannis AU - Kallikas I AD - AAK Ultrasound and Fetal Medicine Centre, 2025 Nicosia, Cyprus. FAU - Kakoullis, Kyriakos AU - Kakoullis K AD - Apollonion Private Hospital, 2054 Nicosia, Cyprus. FAU - Frakala, Sofia AU - Frakala S AD - Ledra Clinic, 1060 Nicosia, Cyprus. FAU - Oxinou, Christina AU - Oxinou C AD - Christina Oxinou Histopathology/Cytology Laboratory, 1065 Nicosia, Cyprus. FAU - Marnerides, Andreas AU - Marnerides A AD - Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK. FAU - Kousoulidou, Ludmila AU - Kousoulidou L AUID- ORCID: 0000-0002-9774-262X AD - The Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, 2371 Nicosia, Cyprus. FAU - Anastasiadou, Violetta C AU - Anastasiadou VC AD - Archbishop Makarios III Hospital, 2012 Nicosia, Cyprus. FAU - Sismani, Carolina AU - Sismani C AUID- ORCID: 0000-0002-9296-8347 AD - The Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, 2371 Nicosia, Cyprus. LA - eng PT - Journal Article DEP - 20240118 PL - Switzerland TA - Genes (Basel) JT - Genes JID - 101551097 RN - 0 (Vitamins) RN - 0 (Sodium Channels) RN - 0 (SCN4A protein, human) RN - 0 (NAV1.4 Voltage-Gated Sodium Channel) SB - IM MH - Female MH - Pregnancy MH - Humans MH - *Channelopathies MH - Cohort Studies MH - Vitamins MH - Sodium Channels MH - Fetus/diagnostic imaging MH - *Abnormalities, Multiple MH - NAV1.4 Voltage-Gated Sodium Channel PMC - PMC10815715 OTO - NOTNLM OT - SCN2A OT - SCN4A OT - epileptic encephalopathy OT - severe fetal congenital myopathy 22B OT - voltage-gated sodium channels OT - whole-exome sequencing COIS- The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. EDAT- 2024/01/23 06:43 MHDA- 2024/01/24 06:43 PMCR- 2024/01/18 CRDT- 2024/01/23 01:05 PHST- 2023/12/21 00:00 [received] PHST- 2024/01/08 00:00 [revised] PHST- 2024/01/17 00:00 [accepted] PHST- 2024/01/24 06:43 [medline] PHST- 2024/01/23 06:43 [pubmed] PHST- 2024/01/23 01:05 [entrez] PHST- 2024/01/18 00:00 [pmc-release] AID - genes15010119 [pii] AID - genes-15-00119 [pii] AID - 10.3390/genes15010119 [doi] PST - epublish SO - Genes (Basel). 2024 Jan 18;15(1):119. doi: 10.3390/genes15010119.